SciELO - Scientific Electronic Library Online

 
vol.46 número3Patient-reported outcomes y aplicaciones móviles. Revisión de su impacto en los resultados en salud de los pacientesAnálisis de la certificación en el marco de especialización farmacéutica a nivel internacional índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Farmacia Hospitalaria

versión On-line ISSN 2171-8695versión impresa ISSN 1130-6343

Resumen

SULAIMAN, Helmi; ROBERTS, Jason A  y  ABDUL–AZIZ, Mohd H. Pharmacokinetics and pharmacodynamics of beta-lactam antibiotics in critically ill patients. Farm Hosp. [online]. 2022, vol.46, n.3, pp.182-190.  Epub 25-Jul-2022. ISSN 2171-8695.  https://dx.doi.org/10.7399/fh.13170.

Optimal antibiotic therapy for critically ill patients can be complicated by the altered physiology associated with critical illness. Antibiotic pharmacokinetics and exposures can be altered driven by the underlying critical illness and medical interventions that critically ill patients receive in the intensive care unit. Furthermore, pathogens that are usually isolated in the intensive care unit are commonly less susceptible and “resistant” to common antibiotics. Indeed, antibiotic dosing that does not consider these unique differences will likely fail leading to poor clinical outcomes and the emergence of antibiotic resistance in the intensive care unit. The aims of this narrative review were to describe the pharmacokinetics of beta-lactam antibiotics in critically ill patients, to highlight pharmacokinetic/pharmacodynamic targets for both non-critically ill and critically ill patients, and to discuss important strategies that can be undertaken to optimize beta-lactam antibiotic dosing for critically ill patients in the intensive care unit.

Palabras clave : Antibiotics; Beta-lactamics; Criticaly ill patient; Clinical pharmacokinetics.

        · resumen en Español     · texto en Español | Inglés     · Español ( pdf ) | Inglés ( pdf )